Prostate specific membrane antigen (PSMA) is a membrane protein that serves as a useful molecular diagnostic marker and a potential druggable surface target preferentially expressed by cancer cells or tumor-associated neovasculature [17–19]. The gene discussed is FOLH1; the disease is cancer.